Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2015

01.03.2015 | Maternal-Fetal Medicine

Anesthetic management of prophylactic cervical cerclage: a retrospective multicenter cohort study

verfasst von: Alexander Ioscovich, Alla Popov, Yuri Gimelfarb, Yaacov Gozal, Sharon Orbach-Zinger, Joel Shapiro, Yehuda Ginosar

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Cervical incompetence complicates approximately 1 in 500 pregnancies and is the most common cause of second-trimester spontaneous abortion and preterm labor. No prospective or large retrospective studies have compared regional and general anesthesia for cervical cerclage.

Study design

Following IRB approval, we performed a retrospective study in the two main medical centers over an 8-year period to assess the association of anesthesia choice with anesthetic and obstetric outcomes. Anesthetic and perioperative details were retrospectively collected from fails of all patients undergoing cervical cerclage from 01/01/2005 until 31/12/2012. Details included demographic data, anesthetic technique, PACU data and perioperative complications.

Results

We identified 487 cases of cervical cerclage in 327 women during the study period. The most commonly used anesthetic technique was general anesthesia (GA) (402/487; 82.5 %) compared with regional anesthesia (RA) (85/487; 17.5 %). When GA was performed, facemask was the most commonly used technique (275/402; 68.4 %), followed by intravenous deep sedation (61/402; 15.2 %); LMA (51/402; 12.7 %) and tracheal intubation (13/402; 3.2 %). There were no significant differences in demographic characteristics between women receiving general and regional anesthesia. Average duration of suturing the cervix among the GA group was 9.8 ± 1.6 and 10.6 ± 2.1 min in the RA group (p < 0.001). Average length of stay in the operating room in the GA group was 20.5 ± 3.9 and 23 ± 4.6 min in the RA group (p < 0.001). Patients receiving GA received in the PACU more opioids (6.2 versus 1.2 %; p < 0.05) and more non-opioids analgesics (36.8 versus 9.4 %; p < 0.001). Duration of PACU stay was shorter after GA (49.5 ± 18 min) than after RA (62.4 ± 28 min; p < 0.001). There were no other differences in anesthetic or perioperative outcome between groups. This study was not designed to provide evidence that RA reduces the risk of pulmonary aspiration, airway complications or adverse fetal neurological effects from maternal anesthetic exposure.

Conclusions

Both regional and general anesthesia were safely used for the performance of cerclage. Patients after general anesthesia had a shorter recovery time but a higher demand for opioids and non-opioids analgesia.
Literatur
1.
Zurück zum Zitat Fox NS, Chervenak FA (2008) Cervical cerclage: a review of the evidence. Obstet Gynecol Surv 63:58–65PubMedCrossRef Fox NS, Chervenak FA (2008) Cervical cerclage: a review of the evidence. Obstet Gynecol Surv 63:58–65PubMedCrossRef
2.
Zurück zum Zitat Debbs RH, Chen J (2009) Contemporary use of cerclage in pregnancy. Clin Obstet Gynecol 52:597–610PubMedCrossRef Debbs RH, Chen J (2009) Contemporary use of cerclage in pregnancy. Clin Obstet Gynecol 52:597–610PubMedCrossRef
4.
Zurück zum Zitat Owen J, Mancuso M (2012) Cervical cerclage for the prevention of preterm birth. Obstet Gynecol Clin North Am 39:25–33PubMedCrossRef Owen J, Mancuso M (2012) Cervical cerclage for the prevention of preterm birth. Obstet Gynecol Clin North Am 39:25–33PubMedCrossRef
5.
Zurück zum Zitat Yoon HJ, Hong JY, Kim SM (2008) The effect of anesthetic method for prophylactic cervical cerclage on plasma oxytocin: a randomized trial. Int J Obstet Anesth 17:26–30PubMedCrossRef Yoon HJ, Hong JY, Kim SM (2008) The effect of anesthetic method for prophylactic cervical cerclage on plasma oxytocin: a randomized trial. Int J Obstet Anesth 17:26–30PubMedCrossRef
6.
Zurück zum Zitat Lee GY, Kim CH, Chung rk et al (2009) Spread of subarachnoid sensory block with hyperbaric bupivacaine in second trimester of pregnancy. J Clin Anesth 21:482–485PubMedCrossRef Lee GY, Kim CH, Chung rk et al (2009) Spread of subarachnoid sensory block with hyperbaric bupivacaine in second trimester of pregnancy. J Clin Anesth 21:482–485PubMedCrossRef
7.
Zurück zum Zitat Schumann R, Rafique MB (2003) Low-dose epidural anesthesia for cervical cerclage. Can J Anaesth 50:424–425PubMedCrossRef Schumann R, Rafique MB (2003) Low-dose epidural anesthesia for cervical cerclage. Can J Anaesth 50:424–425PubMedCrossRef
8.
Zurück zum Zitat Carlin A, Alfirevic Z (2008) Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol 22:801–823PubMedCrossRef Carlin A, Alfirevic Z (2008) Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol 22:801–823PubMedCrossRef
9.
Zurück zum Zitat Loebstein R, Lalkin A, Koren G (1997) Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33:328–343PubMedCrossRef Loebstein R, Lalkin A, Koren G (1997) Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33:328–343PubMedCrossRef
10.
Zurück zum Zitat Kuczkowski KM (2004) Nonobstetric surgery during pregnancy: what are the risks of anesthesia? Obstet Gynecol Surv 59:52–56PubMedCrossRef Kuczkowski KM (2004) Nonobstetric surgery during pregnancy: what are the risks of anesthesia? Obstet Gynecol Surv 59:52–56PubMedCrossRef
11.
Zurück zum Zitat Rosen MA (1999) Management of anesthesia for the pregnant surgical patient. Anesthesiology 91:1159–1163PubMedCrossRef Rosen MA (1999) Management of anesthesia for the pregnant surgical patient. Anesthesiology 91:1159–1163PubMedCrossRef
12.
Zurück zum Zitat Palahniuk RJ, Shnider SM, Eger EI 2nd (1974) Pregnancy decreases the requirement for inhaled anesthetic agents. Anesthesiology 41:82–83PubMedCrossRef Palahniuk RJ, Shnider SM, Eger EI 2nd (1974) Pregnancy decreases the requirement for inhaled anesthetic agents. Anesthesiology 41:82–83PubMedCrossRef
14.
Zurück zum Zitat Van De Velde M, De Buck F (2007) Anesthesia for non-obstetric surgery in the pregnant patient. Minerva Anestesiol 73:235–240 Van De Velde M, De Buck F (2007) Anesthesia for non-obstetric surgery in the pregnant patient. Minerva Anestesiol 73:235–240
15.
Zurück zum Zitat Reitman E, Flood P (2011) Anaesthetic considerations for non-obstetric surgery during pregnancy. Br J Anaesth 107(Suppl 1):72–78CrossRef Reitman E, Flood P (2011) Anaesthetic considerations for non-obstetric surgery during pregnancy. Br J Anaesth 107(Suppl 1):72–78CrossRef
16.
Zurück zum Zitat Barash PG, Cullen BF, Stoelting RK, Cahalan M, Stock MC (eds) (2009) Clinical anesthesia, 6th edn. Lippincott Williams & Wilkins, Philadelphia Barash PG, Cullen BF, Stoelting RK, Cahalan M, Stock MC (eds) (2009) Clinical anesthesia, 6th edn. Lippincott Williams & Wilkins, Philadelphia
17.
Zurück zum Zitat Chestnut D (eds) (2004) Obstetric anesthesia: principles and practice, 3rd edn Chestnut D (eds) (2004) Obstetric anesthesia: principles and practice, 3rd edn
18.
Zurück zum Zitat Beck-Schimmer B, Bonvini JM (2011) Bronchoaspiration: incidence, consequences and management. Eur J Anaesthesiol 28:78–84PubMedCrossRef Beck-Schimmer B, Bonvini JM (2011) Bronchoaspiration: incidence, consequences and management. Eur J Anaesthesiol 28:78–84PubMedCrossRef
19.
Zurück zum Zitat Paranjothy S, Griffiths JD, Broughton HK, Gyte GM, Brown HC, Thomas J (2014) Interventions at caesarean section for reducing the risk of aspiration pneumonitis. Cochrane Database Syst Rev 2:CD004943PubMed Paranjothy S, Griffiths JD, Broughton HK, Gyte GM, Brown HC, Thomas J (2014) Interventions at caesarean section for reducing the risk of aspiration pneumonitis. Cochrane Database Syst Rev 2:CD004943PubMed
20.
Zurück zum Zitat Palanisamy A (2012) Maternal anesthesia and fetal neurodevelopment. Int J Obstet Anesth 21:152–162PubMedCrossRef Palanisamy A (2012) Maternal anesthesia and fetal neurodevelopment. Int J Obstet Anesth 21:152–162PubMedCrossRef
21.
Zurück zum Zitat Sanders RD, Hassell J, Davidson AJ, Robertson NJ, Ma D (2013) Impact of anaesthetics and surgery on neurodevelopment: an update. Br J Anaesth 110(Suppl 1):i53–i72PubMedCentralPubMedCrossRef Sanders RD, Hassell J, Davidson AJ, Robertson NJ, Ma D (2013) Impact of anaesthetics and surgery on neurodevelopment: an update. Br J Anaesth 110(Suppl 1):i53–i72PubMedCentralPubMedCrossRef
Metadaten
Titel
Anesthetic management of prophylactic cervical cerclage: a retrospective multicenter cohort study
verfasst von
Alexander Ioscovich
Alla Popov
Yuri Gimelfarb
Yaacov Gozal
Sharon Orbach-Zinger
Joel Shapiro
Yehuda Ginosar
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3391-5

Weitere Artikel der Ausgabe 3/2015

Archives of Gynecology and Obstetrics 3/2015 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.